{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T04:51:25Z","timestamp":1781067085555,"version":"3.54.1"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T00:00:00Z","timestamp":1689033600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100006512","name":"School of Medicine, Duke University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006512","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Addict Sci Clin Pract"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Acute care inpatient admissions outside of psychiatric facilities have been increasingly identified as a critical touchpoint for opioid use disorder (OUD) treatment. We sought to describe non-opioid overdose hospitalizations with documented OUD and examine receipt of post-discharge outpatient buprenorphine.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We examined acute care hospitalizations with an OUD diagnosis in any position within US commercially-insured adults age 18\u201364\u00a0years (IBM MarketScan claims, 2013\u20132017), excluding opioid overdose diagnoses. We included individuals with\u2009\u2265\u20096\u00a0months of continuous enrollment prior to the index hospitalization and\u2009\u2265\u200910\u00a0days following discharge. We described demographic and hospitalization characteristics, including outpatient buprenorphine receipt within 10\u00a0days of discharge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Most (87%) hospitalizations with documented OUD did not include opioid overdose. Of 56,717 hospitalizations (49,959 individuals), 56.8% had a primary diagnosis other than OUD, 37.0% had documentation of an alcohol-related diagnosis code, and 5.8% end in a self-directed discharge. Where opioid use disorder was not the primary diagnosis,\u00a036.5% were due to other substance use disorders, and 23.1% were due to psychiatric disorders. Of all non-overdose hospitalizations who had prescription medication insurance coverage <jats:italic>and<\/jats:italic> who were discharged to an outpatient setting (n\u2009=\u200949, 237), 8.8% filled an outpatient buprenorphine prescription within 10\u00a0days of discharge.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Non-overdose OUD hospitalizations often occur with substance use disorders and psychiatric disorders, and very few are followed by timely outpatient buprenorphine. Addressing the OUD treatment gap during hospitalization may include implementing medication for OUD for inpatients with a broad range of diagnoses.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s13722-023-00396-9","type":"journal-article","created":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T14:02:03Z","timestamp":1689084123000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Non-overdose acute care hospitalizations for opioid use disorder among commercially-insured adults: a retrospective cohort study"],"prefix":"10.1186","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8659-189X","authenticated-orcid":false,"given":"Sudha R.","family":"Raman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassie B.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley G.","family":"Hammill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy G.","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana C.","family":"Clifton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George L.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,7,11]]},"reference":[{"key":"396_CR1","unstructured":"Ahmad FB, Cisewski JA, Rossen LM, Sutton P. Provisional drug overdose death counts. National Center for Health Statistics; 2023."},{"key":"396_CR2","doi-asserted-by":"publisher","DOI":"10.1001\/jamapsychiatry.2021.0247","author":"M Fairley","year":"2021","unstructured":"Fairley M, Humphreys K, Joyce VR, Bounthavong M, Trafton J, Combs A, et al. Cost-effectiveness of treatments for opioid use disorder. JAMA Psychiatr. 2021. https:\/\/doi.org\/10.1001\/jamapsychiatry.2021.0247.","journal-title":"JAMA Psychiatr"},{"key":"396_CR3","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.j1550","volume":"357","author":"L Sordo","year":"2017","unstructured":"Sordo L, Barrio G, Bravo MJ, Indave BI, Degenhardt L, Wiessing L, et al. Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studies. BMJ. 2017;357: j1550.","journal-title":"BMJ"},{"issue":"3","key":"396_CR4","doi-asserted-by":"publisher","first-page":"137","DOI":"10.7326\/M17-3107","volume":"169","author":"MR Larochelle","year":"2018","unstructured":"Larochelle MR, Bernson D, Land T, Stopka TJ, Wang N, Xuan Z, et al. Medication for opioid use disorder after nonfatal opioid overdose and association with mortality: a cohort study. Ann Intern Med. 2018;169(3):137\u201345.","journal-title":"Ann Intern Med"},{"key":"396_CR5","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.drugalcdep.2016.10.015","volume":"169","author":"LT Wu","year":"2016","unstructured":"Wu LT, Zhu H, Swartz MS. Treatment utilization among persons with opioid use disorder in the United States. Drug Alcohol Depend. 2016;169:117\u201327.","journal-title":"Drug Alcohol Depend"},{"issue":"2","key":"396_CR6","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1097\/ADM.0000000000000496","volume":"13","author":"KC Priest","year":"2019","unstructured":"Priest KC, McCarty D. Role of the hospital in the 21st century opioid overdose epidemic: the addiction medicine consult service. J Addict Med. 2019;13(2):104\u201312.","journal-title":"J Addict Med"},{"issue":"8","key":"396_CR7","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1176\/appi.ps.201600339","volume":"68","author":"S Reif","year":"2017","unstructured":"Reif S, Acevedo A, Garnick DW, Fullerton CA. Reducing behavioral health inpatient readmissions for people with substance use disorders: do follow-up services matter? Psychiatr Serv. 2017;68(8):810\u20138.","journal-title":"Psychiatr Serv"},{"issue":"2","key":"396_CR8","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1007\/s11414-013-9323-5","volume":"40","author":"TL Mark","year":"2013","unstructured":"Mark TL, Tomic KS, Kowlessar N, Chu BC, Vandivort-Warren R, Smith S. Hospital readmission among medicaid patients with an index hospitalization for mental and\/or substance use disorder. J Behav Health Serv Res. 2013;40(2):207\u201321.","journal-title":"J Behav Health Serv Res"},{"issue":"6","key":"396_CR9","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.amepre.2018.12.003","volume":"56","author":"C Peterson","year":"2019","unstructured":"Peterson C, Liu Y, Xu L, Nataraj N, Zhang K, Mikosz CAUS. National 90-day readmissions after opioid overdose discharge. Am J Prev Med. 2019;56(6):875\u201381.","journal-title":"Am J Prev Med"},{"issue":"4","key":"396_CR10","doi-asserted-by":"publisher","first-page":"ofz089","DOI":"10.1093\/ofid\/ofz089","volume":"6","author":"PA Leahey","year":"2019","unstructured":"Leahey PA, LaSalvia MT, Rosenthal ES, Karchmer AW, Rowley CF. High morbidity and mortality among patients with sentinel admission for injection drug use-related infective endocarditis. Open Forum Infect Dis. 2019;6(4):ofz089.","journal-title":"Open Forum Infect Dis"},{"issue":"12","key":"396_CR11","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1377\/hlthaff.2017.0689","volume":"36","author":"Z Song","year":"2017","unstructured":"Song Z. Mortality quadrupled among opioid-driven hospitalizations, notably within lower-income and disabled white populations. Health Affairs. 2017;36(12):2054\u201361.","journal-title":"Health Affairs"},{"issue":"4","key":"396_CR12","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1097\/ADM.0000000000000312","volume":"11","author":"YI Hser","year":"2017","unstructured":"Hser YI, Mooney LJ, Saxon AJ, Miotto K, Bell DS, Zhu Y, et al. High mortality among patients with opioid use disorder in a large healthcare system. J Addict Med. 2017;11(4):315\u20139.","journal-title":"J Addict Med"},{"key":"396_CR13","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.jsat.2019.05.003","volume":"103","author":"C Peterson","year":"2019","unstructured":"Peterson C, Xu L, Florence C, Mack KA. Opioid-related US hospital discharges by type, 1993\u20132016. J Subst Abuse Treat. 2019;103:9\u201313.","journal-title":"J Subst Abuse Treat"},{"key":"396_CR14","unstructured":"Ali MM, Mutter R. Patients who are privately insured receive limited follow-up services after opioid-related hospitalizations. The CBHSQ Report. Rockville (MD): Substance Abuse and Mental Health Services Administration (US); 2016. p. 1\u20134."},{"issue":"22","key":"396_CR15","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","volume":"66","author":"AT Fleischauer","year":"2017","unstructured":"Fleischauer AT, Ruhl L, Rhea S, Barnes E. Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence\u2014North Carolina, 2010\u20132015. MMWR Morb Mortal Wkly Rep. 2017;66(22):569\u201373.","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"6","key":"396_CR16","doi-asserted-by":"publisher","first-page":"461","DOI":"10.1097\/ADM.0000000000000346","volume":"11","author":"KT Phillips","year":"2017","unstructured":"Phillips KT, Anderson BJ, Herman DS, Liebschutz JM, Stein MD. Risk factors associated with skin and soft tissue infections among hospitalized people who inject drugs. J Addict Med. 2017;11(6):461\u20137.","journal-title":"J Addict Med"},{"issue":"7","key":"396_CR17","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.1093\/cid\/ciy632","volume":"68","author":"AC Miller","year":"2019","unstructured":"Miller AC, Polgreen PM. Many opportunities to record, diagnose, or treat injection drug-related infections are missed: a population-based cohort study of inpatient and emergency department settings. Clin Infect Dis. 2019;68(7):1166\u201375.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"396_CR18","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1097\/MLR.0000000000001233","volume":"58","author":"KA Schuller","year":"2020","unstructured":"Schuller KA, Franz B, Cronin CE. Patient characteristics affect discharge status for opioid-related infective endocarditis. Med Care. 2020;58(1):13\u20137.","journal-title":"Med Care"},{"issue":"10","key":"396_CR19","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.16228","volume":"3","author":"SD Kimmel","year":"2020","unstructured":"Kimmel SD, Walley AY, Li Y, Linas BP, Lodi S, Bernson D, et al. Association of treatment with medications for opioid use disorder with mortality after hospitalization for injection drug use-associated infective endocarditis. JAMA Netw Open. 2020;3(10): e2016228.","journal-title":"JAMA Netw Open"},{"issue":"1","key":"396_CR20","doi-asserted-by":"publisher","first-page":"61","DOI":"10.7326\/M20-1212","volume":"173","author":"ND Volkow","year":"2020","unstructured":"Volkow ND. Collision of the COVID-19 and addiction epidemics. Ann Intern Med. 2020;173(1):61\u20132.","journal-title":"Ann Intern Med"},{"key":"396_CR21","unstructured":"Centers for Disease Control and Prevention. National Center for Health Statistics Monthly Provision Overdose Mortality. 2021."},{"key":"396_CR22","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1016\/j.jsat.2018.06.008","volume":"92","author":"C Peterson","year":"2018","unstructured":"Peterson C, Xu L, Mikosz CA, Florence C, Mack KA. US hospital discharges documenting patient opioid use disorder without opioid overdose or treatment services, 2011\u20132015. J Subst Abuse Treat. 2018;92:35\u20139.","journal-title":"J Subst Abuse Treat"},{"issue":"1","key":"396_CR23","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1186\/s13722-019-0135-7","volume":"14","author":"J McNeely","year":"2019","unstructured":"McNeely J, Troxel AB, Kunins HV, Shelley D, Lee JD, Walley A, et al. Study protocol for a pragmatic trial of the consult for addiction treatment and care in hospitals (CATCH) model for engaging patients in opioid use disorder treatment. Addict Sci Clin Pract. 2019;14(1):5.","journal-title":"Addict Sci Clin Pract"},{"key":"396_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/s11606-019-05251-9","author":"H Englander","year":"2019","unstructured":"Englander H, Dobbertin K, Lind BK, Nicolaidis C, Graven P, Dorfman C, et al. Inpatient addiction medicine consultation and post-hospital substance use disorder treatment engagement: a propensity-matched analysis. J General Int Med. 2019. https:\/\/doi.org\/10.1007\/s11606-019-05251-9.","journal-title":"J General Int Med"},{"issue":"8","key":"396_CR25","doi-asserted-by":"publisher","first-page":"909","DOI":"10.1007\/s11606-017-4077-z","volume":"32","author":"SE Wakeman","year":"2017","unstructured":"Wakeman SE, Metlay JP, Chang Y, Herman GE, Rigotti NA. Inpatient addiction consultation for hospitalized patients increases post-discharge abstinence and reduces addiction severity. J Gen Intern Med. 2017;32(8):909\u201316.","journal-title":"J Gen Intern Med"},{"key":"396_CR26","unstructured":"L.; H. IBM MarketScan Research Databases for life sciences researchers. Truven Health Analytics; 2018."},{"key":"396_CR27","unstructured":"Administration SAaMHS. Medications for Opioid Use Disorder. 2020. Contract No.: PEP20\u201302\u201301\u2013006."},{"issue":"4","key":"396_CR28","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1080\/13696998.2018.1427101","volume":"21","author":"A Shah","year":"2018","unstructured":"Shah A, Duncan M, Atreja N, Tai KS, Gore M. Healthcare utilization and costs associated with treatment for opioid dependence. J Med Econ. 2018;21(4):406\u201315.","journal-title":"J Med Econ"},{"key":"396_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jsat.2017.05.007","volume":"79","author":"P Trowbridge","year":"2017","unstructured":"Trowbridge P, Weinstein ZM, Kerensky T, Roy P, Regan D, Samet JH, et al. Addiction consultation services\u2014linking hospitalized patients to outpatient addiction treatment. J Subst Abuse Treat. 2017;79:1\u20135.","journal-title":"J Subst Abuse Treat"},{"issue":"2","key":"396_CR30","doi-asserted-by":"publisher","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","volume":"110","author":"TJ Cicero","year":"2020","unstructured":"Cicero TJ, Ellis MS, Kasper ZA. Polysubstance use: a broader understanding of substance use during the opioid crisis. Am J Public Health. 2020;110(2):244\u201350.","journal-title":"Am J Public Health"},{"key":"396_CR31","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1016\/j.drugalcdep.2018.12.030","volume":"197","author":"CM Jones","year":"2019","unstructured":"Jones CM, McCance-Katz EF. Co-occurring substance use and mental disorders among adults with opioid use disorder. Drug Alcohol Depend. 2019;197:78\u201382.","journal-title":"Drug Alcohol Depend"},{"key":"396_CR32","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.jsat.2017.12.003","volume":"86","author":"AG Robertson","year":"2018","unstructured":"Robertson AG, Easter MM, Lin HJ, Frisman LK, Swanson JW, Swartz MS. Associations between pharmacotherapy for opioid dependence and clinical and criminal justice outcomes among adults with co-occurring serious mental illness. J Subst Abuse Treat. 2018;86:17\u201325.","journal-title":"J Subst Abuse Treat"},{"issue":"3","key":"396_CR33","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/ajad.12349","volume":"25","author":"J Suzuki","year":"2016","unstructured":"Suzuki J. Medication-assisted treatment for hospitalized patients with intravenous-drug-use related infective endocarditis. Am J Addict. 2016;25(3):191\u20134.","journal-title":"Am J Addict"},{"issue":"5","key":"396_CR34","doi-asserted-by":"publisher","first-page":"339","DOI":"10.12788\/jhm.2736","volume":"12","author":"H Englander","year":"2017","unstructured":"Englander H, Weimer M, Solotaroff R, Nicolaidis C, Chan B, Velez C, et al. Planning and designing the improving addiction care team (IMPACT) for hospitalized adults with substance use disorder. J Hosp Med. 2017;12(5):339\u201342.","journal-title":"J Hosp Med"},{"issue":"1","key":"396_CR35","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1111\/add.15116","volume":"116","author":"LA Lin","year":"2021","unstructured":"Lin LA, Bohnert ASB, Blow FC, Gordon AJ, Ignacio RV, Kim HM, et al. Polysubstance use and association with opioid use disorder treatment in the US veterans health administration. Addiction. 2021;116(1):96\u2013104.","journal-title":"Addiction"},{"issue":"6","key":"396_CR36","doi-asserted-by":"publisher","first-page":"708","DOI":"10.1016\/j.amjmed.2019.01.023","volume":"132","author":"N Kumar","year":"2019","unstructured":"Kumar N. Burden of 30-day readmissions associated with discharge against medical advice among inpatients in the United States. Am J Med. 2019;132(6):708-17.e4.","journal-title":"Am J Med"},{"issue":"9","key":"396_CR37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0024459","volume":"6","author":"M Choi","year":"2011","unstructured":"Choi M, Kim H, Qian H, Palepu A. Readmission rates of patients discharged against medical advice: a matched cohort study. PLoS ONE. 2011;6(9): e24459.","journal-title":"PLoS ONE"},{"issue":"3","key":"396_CR38","doi-asserted-by":"publisher","first-page":"ofaa074","DOI":"10.1093\/ofid\/ofaa074","volume":"7","author":"EF Eaton","year":"2020","unstructured":"Eaton EF, Westfall AO, McClesky B, Paddock CS, Lane PS, Cropsey KL, et al. In-hospital illicit drug use and patient-directed discharge: barriers to care for patients with injection-related infections. Open forum infectious diseases. 2020;7(3):ofaa074.","journal-title":"Open forum infectious diseases."},{"key":"396_CR39","unstructured":"Lipari RNVH, S.L. Trends in substance use disorders among adults aged 18 or older. Rockville, MD: Substance abuse and mental health services administration; 2017."},{"key":"396_CR40","doi-asserted-by":"publisher","DOI":"10.1016\/j.addbeh.2019.106031","volume":"98","author":"RD Ashford","year":"2019","unstructured":"Ashford RD, Brown AM, McDaniel J, Neasbitt J, Sobora C, Riley R, et al. Responding to the opioid and overdose crisis with innovative services: the recovery community center office-based opioid treatment (RCC-OBOT) model. Addict Behav. 2019;98: 106031.","journal-title":"Addict Behav"},{"issue":"5","key":"396_CR41","doi-asserted-by":"publisher","first-page":"376","DOI":"10.7326\/L16-0168","volume":"165","author":"MR Larochelle","year":"2016","unstructured":"Larochelle MR, Liebschutz JM, Zhang F, Ross-Degnan D, Wharam JF. Opioid prescribing after nonfatal overdose and association with repeated overdose. Ann Intern Med. 2016;165(5):376\u20137.","journal-title":"Ann Intern Med"},{"issue":"11","key":"396_CR42","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1176\/appi.ps.201500538","volume":"67","author":"S Naeger","year":"2016","unstructured":"Naeger S, Ali MM, Mutter R, Mark TL, Hughey L. Prescriptions Filled Following an Opioid-Related Hospitalization. Psychiatr Serv. 2016;67(11):1262\u20134.","journal-title":"Psychiatr Serv"},{"issue":"6","key":"396_CR43","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1002\/jhm.12837","volume":"17","author":"D Clifton","year":"2022","unstructured":"Clifton D, Ivey N, Poley S, O\u2019Regan A, Raman SR, Frascino N, et al. Implementation of a comprehensive hospitalist-led initiative to improve care for patients with opioid use disorder. J Hosp Med. 2022;17(6):427\u201336.","journal-title":"J Hosp Med"},{"issue":"6","key":"396_CR44","doi-asserted-by":"publisher","first-page":"345","DOI":"10.12788\/jhm.3591","volume":"16","author":"N Christian","year":"2021","unstructured":"Christian N, Bottner R, Baysinger A, Boulton A, Walker B, Valencia V, et al. Hospital buprenorphine program for opioid use disorder is associated with increased inpatient and outpatient addiction treatment. J Hosp Med. 2021;16(6):345\u20138.","journal-title":"J Hosp Med"},{"issue":"1","key":"396_CR45","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13012-019-0891-5","volume":"14","author":"G D'Onofrio","year":"2019","unstructured":"D\u2019Onofrio G, Edelman EJ, Hawk KF, Pantalon MV, Chawarski MC, Owens PH, et al. Implementation facilitation to promote emergency department-initiated buprenorphine for opioid use disorder: protocol for a hybrid type III effectiveness-implementation study (project ED HEALTH). Implement Sci IS. 2019;14(1):48.","journal-title":"Implement Sci IS"},{"issue":"1","key":"396_CR46","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13012-018-0777-y","volume":"13","author":"SB Hunter","year":"2018","unstructured":"Hunter SB, Ober AJ, McCullough CM, Storholm ED, Iyiewuare PO, Pham C, et al. Sustaining alcohol and opioid use disorder treatment in primary care: a mixed methods study. Implement Sci IS. 2018;13(1):83.","journal-title":"Implement Sci IS"},{"issue":"10","key":"396_CR47","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0239761","volume":"15","author":"HM Thompson","year":"2020","unstructured":"Thompson HM, Faig W, VanKim NA, Sharma B, Afshar M, Karnik NS. Differences in length of stay and discharge destination among patients with substance use disorders: The effect of Substance Use Intervention Team (SUIT) consultation service. PLoS ONE. 2020;15(10): e0239761.","journal-title":"PLoS ONE"},{"key":"396_CR48","doi-asserted-by":"publisher","DOI":"10.7326\/M20-5475","author":"J Gryczynski","year":"2021","unstructured":"Gryczynski J, Nordeck CD, Welsh C, Mitchell SG, O\u2019Grady KE, Schwartz RP. Preventing hospital readmission for patients with comorbid substance use disorder\u202f: a randomized trial. Annal Int Med. 2021. https:\/\/doi.org\/10.7326\/M20-5475.","journal-title":"Annal Int Med"},{"issue":"6","key":"396_CR49","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1097\/MLR.0000000000000918","volume":"56","author":"HA Huskamp","year":"2018","unstructured":"Huskamp HA, Riedel LE, Barry CL, Busch AB. Coverage of medications that treat opioid use disorder and opioids for pain management in marketplace plans, 2017. Med Care. 2018;56(6):505\u20139.","journal-title":"Med Care"},{"issue":"6","key":"396_CR50","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1007\/s00439-012-1168-0","volume":"131","author":"KR Merikangas","year":"2012","unstructured":"Merikangas KR, McClair VL. Epidemiology of substance use disorders. Hum Genet. 2012;131(6):779\u201389.","journal-title":"Hum Genet"}],"container-title":["Addiction Science &amp; Clinical Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00396-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13722-023-00396-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13722-023-00396-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,11]],"date-time":"2023-07-11T15:05:26Z","timestamp":1689087926000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpjournal.biomedcentral.com\/articles\/10.1186\/s13722-023-00396-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,11]]},"references-count":50,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["396"],"URL":"https:\/\/doi.org\/10.1186\/s13722-023-00396-9","relation":{},"ISSN":["1940-0640"],"issn-type":[{"value":"1940-0640","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,11]]},"assertion":[{"value":"6 September 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was determined exempt from review by the Duke Health Institutional Review Board (#00103945). IBM Marketscan data comply with the statistical de-identification provisions of the HIPAA Privacy Rule.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Dr. Sudha Raman reports grant funding from GSK outside the area of the submitted work. Other authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}